Shavandi, Mehrdad <br/><br/>
Silymarin (Livergol®) Decreases Disease Activity Score in Patients with Rheumatoid Arthritis: A Non-randomized Single-arm Clinical Trial.  [electronic resource] 

 -  Iranian journal of allergy, asthma, and immunology  Apr 2017 
 - 99-106 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>1735-1502 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antirheumatic Agents--therapeutic use<br/>Arthritis, Rheumatoid--diagnosis<br/>Biomarkers<br/>C-Reactive Protein<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Severity of Illness Index<br/>Silymarin--therapeutic use<br/>Treatment Outcome<br/>Young Adult